Cor Vasa 2019, 61(2):e238-e244 | DOI: 10.33678/cor.2019.017

Doporučení pro deaktivaci implantabilních kardioverterů- -defibrilátorů u pacientů v terminální fázi života.Společný dokument odborných společností: České kardiologické společnosti, z.s.; České společnosti paliativní medicíny ČLS JEP; České gerontologické a geriatrické společnosti ČLS JEP

Martin Gřivaa, Miloš Táborskýb, Helena Krejčíkovác, Jaromír Matějekd
a Kardiologické oddělení, Krajská nemocnice T. Bati, a.s., Zlín, Lékařská fakulta Univerzity Palackého, Olomouc (hlavní autor)
b I. interní klinika - kardiologická, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc (korespondující autor)
c Centrum zdravotnického práva, Právnická fakulta Univerzity Karlovy, Praha
d Ústav etiky a humanitních studií, 3. lékařská fakulta Univerzity Karlovy, Praha

The document is dedicated to healthcare workers taking care of patients with implantable cardioverter-defibrillators (ICD) nearing end of life. The aim of the document is to ease the suffering during the process of dying of these people. Guidelines agree with the guidelines of the European expert societies1-5 and are not in contradiction with Czech legal system. The situation in USA differs in some aspects.

Keywords: Deactivation, ICD, Negative patient’s prognosis

Received: April 13, 2019; Accepted: April 15, 2019; Published: May 8, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gřiva M, Táborský M, Krejčíková H, Matějek J. Doporučení pro deaktivaci implantabilních kardioverterů- -defibrilátorů u pacientů v terminální fázi života.Společný dokument odborných společností: České kardiologické společnosti, z.s.; České společnosti paliativní medicíny ČLS JEP; České gerontologické a geriatrické společnosti ČLS JEP. Cor Vasa. 2019;61(2):e238-244. doi: 10.33678/cor.2019.017.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Padeletti L, Arnar DO, Boncinelli L, et al. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 2010;12:1480-1489. Go to original source... Go to PubMed...
    2. Ponikowski P, Voors AA, Anker SD, et al. Authors/Task Force Members. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 2016;37:2129-2200. Go to original source... Go to PubMed...
    3. Pitcher D, Soar J, Hogg K, et al; the CIED Working Group. Cardiovascular implanted electronic devices in people towards the end of life, during cardiopulmonary resuscitation and after death: guidance from the Resuscitation Council (UK), British Cardiovascular Society and National Council for Palliative Care. Heart 2016;102:A1-A17. Go to original source... Go to PubMed...
    4. Datino T, Rexach L, Vidán MT, et al. Guidelines on the management of implantable cardioverter defibrillators at the end of life. Rev Clin Esp 2014;214:31-37. Go to original source... Go to PubMed...
    5. Jaarsma T, Beattie JM, Ryder M, et al.; Advanced Heart Failure Study Group of the HFA of the ESC. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009;11:433-443. Go to original source... Go to PubMed...
    6. Lampert R, Hayes DL, Annas GJ, et al. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010;7:1008-1026. Go to original source... Go to PubMed...
    7. Brignole M, Auricchio A, Baron-Esquivias G, et al.; The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2013;34:2281-2329. Go to original source... Go to PubMed...
    8. Westerdahl AK, Sjöblom J, Mattiasson A, et al. Implantable cardioverter-defibrillator therapy before death: High risk for painful shocks at end of life. Circulation 2014;129:422-429. Go to original source... Go to PubMed...
    9. Revenco D, Morgan JP, Tsao L. The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population. J Geriatr Cardiol 2011;8:195-200. Go to original source... Go to PubMed...
    10. Kirkpatrick JN, Gottlieb M, Sehgal P, et al. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care. Am J Cardiol 2012;109:91-94. Go to original source... Go to PubMed...
    11. Dodson JA, Fried TR, van Ness PH, et al. Patient preferences for deactivation of implantable cardioverter-defibrillators. JAMA Intern Med 2013;173:377-379. Go to original source... Go to PubMed...
    12. Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Europace 2008;10:707-725. Go to original source... Go to PubMed...
    13. Council of Europe. Guide on the decision-making process regarding medical treatment in end-of-life situations. Zhlédnuto 12. 4. 2019. Dostupné z https://www.coe.int/en/web/bioethics/guide-on-the-decision-making-process-regarding-medical-treatment-in-end-of-life-situations
    14. Rada Evropy. Úmluva na ochranu lidských práv a důstojnosti lidské bytosti v souvislosti s aplikací biologie a medicíny. Úmluva o lidských právech a biomedicíně. Zhlédnuto 31. 1. 2019. Dostupné z https://www.lkcr.cz/doc/cms_library/96-2001-umluva-o-lid-pravech-a-biomedicine-100419.pdf.
    15. Brady DR. Planning for Deactivation of Implantable Cardioverter Defibrillators at the End of Life in Patients with Heart Failure. Crit Care Nurse 2016;36:24-31. Go to original source... Go to PubMed...
    16. Jox RJ. Entscheidungen über lebensverlängernde Maßnahmen. In: Marckman G, et al. Praxisbuch Ethik in der Medizin. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft, 2018, s. 140.
    17. Česká společnost anesteziologie, resuscitace a intenzivní medicíny ČLS JEP, Česká společnost intenzivní medicíny ČLS JEP - Konsenzuální stanovisko k poskytování paliativní péče u nemocných s nezvratným orgánovým selháním. Verze 1/2009. Zhlédnuto 4. 2. 2019. Dostupné z https://urgmed.cz/wp-content/uploads/2019/03/2009_paliativni.pdf
    18. Doporučení představenstva ČLK č. 1/2010. Zhlédnuto 4. 2. 2019. Dostupné z https://www.lkcr.cz/doc/cms_library/dop-1-2010-31.pdf
    19. Berger JT. The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med 2005;142:631-634. Go to original source... Go to PubMed...
    20. Lewis WR, Luebke DL, Johnson NJ, et al. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med 2006;119:892-896. Go to original source... Go to PubMed...
    21. Mueller PS, Hook CC, Hayes DL. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc 2003;78:959-963. Go to original source...
    22. Ellis G, Whitehead MA, Robinson D, et al. Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ 2011;343:d6553. Go to original source... Go to PubMed...
    23. Herman D, Stros P, Curila K, et al. Deactivation of implantable cardioverter-defibrillators: results of patient surveys. Europace 2013;15:963-969. Go to original source... Go to PubMed...
    24. Stewart GC, Weintraub JR, Pratibhu PP, et al. Patient expectations from implantable defibrillators to prevent death in heart failure. J Cardiac Fail 2010;16:106-113. Go to original source... Go to PubMed...
    25. Lowey SE, Norton SA, Quinn JR, et al. Living with advanced heart failure or COPD: experiences and goals of individuals nearing the end of life. Res Nurs Health 2013:36;349-358. Go to original source... Go to PubMed...
    26. Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death and caregiver bereavement adjustment. JAMA 2008;300:1665-1673. Go to original source... Go to PubMed...
    27. Beets MT, Forringer E. Urgent implantable cardioverter defibrillator deactivation by unconventional means. J Pain Symptom Manage 2011;42:941-945. Go to original source... Go to PubMed...
    28. Gřiva M, et al. Paliativní péče v kardiologii. Praha: Triton, 2018, str. 169-182.

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes